COMPARATIVE EFFECTIVENESS OF DELAYED-RELEASE DIMETHYL FUMARATE VERSUS FINGOLIMOD AND TERIFLUNOMIDE ON RISK OF RELAPSE

被引：0
|
作者：
Nicholas, Jacqueline [1 ]
Boster, Aaron [1 ]
Wu, Ning [2 ]
Huang, Ming-Yi [2 ]
Riester, Katherine [2 ]
Jhaveri, Mehul [2 ]
Edwards, Michael [2 ]
Lee, Andrew [2 ]
机构：
[1] OhioHlth Multiple Sclerosis Ctr, Columbus, OH USA
[2] Biogen, Cambridge, MA USA
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P6.375
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the US
    Ontaneda, Daniel
    Nicholas, Jacqueline
    Carraro, Matthew
    Zhou, Jia
    Hou, Qiang
    Babb, Jaanai
    Riester, Katherine
    Mendoza, Jason P.
    Livingston, Terrie
    Jhaveri, Mehul
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 27 : 101 - 111
  • [22] Delayed-release dimethyl fumarate demonstrated no evidence of difference in clinical outcomes vs fingolimod in patients with RRMS: a propensity-matched comparative effectiveness analysis of the German NeuroTransData registry
    Braune, S.
    Grimm, S.
    van Hoevell, P.
    Freudensprung, U.
    Hyde, R.
    Bergmann, A.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 307 - 307
  • [23] Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centers
    Vollmer, Brandi
    Ontaneda, Daniel
    Bandyopadhyay, Anasua
    Cohn, Sam
    Nair, Kavita
    Sillau, Stefan
    Bermel, Robert A.
    Corboy, John R.
    Fox, Roberti
    Vollmer, Timothy
    Cohen, Jeffrey A.
    Alvarez, Enrique
    Hersh, Carrie M.
    NEUROLOGY-CLINICAL PRACTICE, 2018, 8 (04) : 292 - 301
  • [24] Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study
    Douglas L. Arnold
    Ralf Gold
    Ludwig Kappos
    Amit Bar-Or
    Gavin Giovannoni
    Krzysztof Selmaj
    Minhua Yang
    Ray Zhang
    Monica Stephan
    Sarah I. Sheikh
    Katherine T. Dawson
    Journal of Neurology, 2014, 261 : 2429 - 2437
  • [25] Pregnancy outcomes with delayed-release dimethyl fumarate: preliminary registry results
    Everage, N. J.
    Liu, S.
    Newhook, T.
    Prada, C.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 347 - 348
  • [26] The budget impact of introducing delayed-release dimethyl fumarate for treatment of relapse-remitting multiple sclerosis in Canada
    Dorman, Emily
    Kansal, Anuraag R.
    Sarda, Sujata
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (12) : 1085 - 1091
  • [27] Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study
    Arnold, Douglas L.
    Gold, Ralf
    Kappos, Ludwig
    Bar-Or, Amit
    Giovannoni, Gavin
    Selmaj, Krzysztof
    Yang, Minhua
    Zhang, Ray
    Stephan, Monica
    Sheikh, Sarah I.
    Dawson, Katherine T.
    JOURNAL OF NEUROLOGY, 2014, 261 (12) : 2429 - 2437
  • [28] Comparative analysis of adherence and persistence for delayed-release dimethyl fumarate versus interferons and glatiramer acetate - a population based study in Sweden
    Berglund, A.
    Wu, N.
    Berko, S.
    Lohm, L.
    Ekelund, M.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 309 - 309
  • [29] COST-EFFECTIVENESS ANALYSIS OF DELAYED-RELEASE DIMETHYL FUMARATE FOR THE TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS IN SPAIN
    Gasche, D.
    Restovic, G.
    Casado, V
    Ramirez-Boix, P.
    Martinez Lopez, J.
    VALUE IN HEALTH, 2015, 18 (07) : A755 - A755
  • [30] COST EFFECTIVENESS ANALYSIS OF DIMETHYL FUMARATE VERSUS TERIFLUNOMIDE FOR THE TREATMENT OF MULTIPLE SCLEROSIS
    Ruiz, L.
    Machado, L.
    Toro-Diaz, H.
    Cele, C.
    Hernandez, L.
    Harrington, A.
    VALUE IN HEALTH, 2017, 20 (09) : A724 - A724
12345